FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2750448514> ?p ?o ?g. }

• W2750448514 endingPage "148" @default.
• W2750448514 startingPage "141" @default.
• W2750448514 abstract "Breast cancer (BC) with HER-2/neu overexpression or amplification (HER-2+) is associated with a higher prevalence of brain metastases (BMs) when compared to other subtypes. Among approved drugs for HER-2+ BC, lapatinib (L) is associated with single agent activity toward BMs. We conducted a systematic review to determine the efficacy of L, singly or in combination with capecitabine (C), as a treatment for HER-2+ BMs.We searched PubMed, EMBASE, The Cochrane Library, SCOPUS, Web of Science, ClinicalTrials.gov, World Health Organization International Clinical Trials Registry Platform (ICTRP), and the European Union Clinical Trials Register for studies reporting data on L, singly or in combination with C, for the treatment of HER-2+ BC with BMs. Primary end-points were overall response rate (ORR) and disease control rate (DCR); these were pooled to provide an aggregate value. Progression-free survival (PFS) and overall survival (OS) were secondary end-points. Data were pooled using number of events/number of evaluable patients, according to a fixed or random effect model.Overall, 12 studies were included in the present meta-analysis, for a total of 799 patients with BMs. The pooled overall response rate (ORR) was 21.4% (95% CI 11.7-35.9). After exclusion of patients that received L alone, ORR reached 29.2% (95% CI 18.5-42.7). The pooled median PFS and OS were 4.1 (95% CI 3.1-6.7) and 11.2 (95% CI 8.9-14.1) months, respectively.Due to its activity on BMs, the L + C combination may be considered for HER-2+ BC that has progressed in the brain, when local therapy has been performed or failed and re-irradiation is not feasible." @default.
• W2750448514 created "2017-08-31" @default.
• W2750448514 creator A5003293741 @default.
• W2750448514 creator A5004680827 @default.
• W2750448514 creator A5013554030 @default.
• W2750448514 creator A5032928173 @default.
• W2750448514 creator A5046233482 @default.
• W2750448514 creator A5058439511 @default.
• W2750448514 creator A5061179981 @default.
• W2750448514 creator A5065742446 @default.
• W2750448514 date "2017-10-01" @default.
• W2750448514 modified "2023-09-26" @default.
• W2750448514 title "The efficacy of lapatinib and capecitabine in HER-2 positive breast cancer with brain metastases: A systematic review and pooled analysis" @default.
• W2750448514 cites W1964435302 @default.
• W2750448514 cites W1972202167 @default.
• W2750448514 cites W1975455188 @default.
• W2750448514 cites W1991330252 @default.
• W2750448514 cites W2009949105 @default.
• W2750448514 cites W2012784647 @default.
• W2750448514 cites W2013669698 @default.
• W2750448514 cites W2027025375 @default.
• W2750448514 cites W2034430966 @default.
• W2750448514 cites W2038083527 @default.
• W2750448514 cites W2045424766 @default.
• W2750448514 cites W2062352315 @default.
• W2750448514 cites W2090403447 @default.
• W2750448514 cites W2097010621 @default.
• W2750448514 cites W2098460073 @default.
• W2750448514 cites W2118600577 @default.
• W2750448514 cites W2119997685 @default.
• W2750448514 cites W2125401809 @default.
• W2750448514 cites W2125435699 @default.
• W2750448514 cites W2126930838 @default.
• W2750448514 cites W2127714076 @default.
• W2750448514 cites W2130735457 @default.
• W2750448514 cites W2131558896 @default.
• W2750448514 cites W2138253215 @default.
• W2750448514 cites W2141712412 @default.
• W2750448514 cites W2144686284 @default.
• W2750448514 cites W2157823046 @default.
• W2750448514 cites W2161392588 @default.
• W2750448514 cites W2164190676 @default.
• W2750448514 cites W2167660860 @default.
• W2750448514 cites W2168814163 @default.
• W2750448514 cites W2175378170 @default.
• W2750448514 cites W2315238114 @default.
• W2750448514 cites W2331963379 @default.
• W2750448514 cites W2393325472 @default.
• W2750448514 cites W2519946849 @default.
• W2750448514 cites W2563599068 @default.
• W2750448514 cites W2593310480 @default.
• W2750448514 cites W2595711623 @default.
• W2750448514 cites W2624067448 @default.
• W2750448514 doi "https://doi.org/10.1016/j.ejca.2017.07.024" @default.
• W2750448514 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28810186" @default.
• W2750448514 hasPublicationYear "2017" @default.
• W2750448514 type Work @default.
• W2750448514 sameAs 2750448514 @default.
• W2750448514 citedByCount "84" @default.
• W2750448514 countsByYear W27504485142017 @default.
• W2750448514 countsByYear W27504485142018 @default.
• W2750448514 countsByYear W27504485142019 @default.
• W2750448514 countsByYear W27504485142020 @default.
• W2750448514 countsByYear W27504485142021 @default.
• W2750448514 countsByYear W27504485142022 @default.
• W2750448514 countsByYear W27504485142023 @default.
• W2750448514 crossrefType "journal-article" @default.
• W2750448514 hasAuthorship W2750448514A5003293741 @default.
• W2750448514 hasAuthorship W2750448514A5004680827 @default.
• W2750448514 hasAuthorship W2750448514A5013554030 @default.
• W2750448514 hasAuthorship W2750448514A5032928173 @default.
• W2750448514 hasAuthorship W2750448514A5046233482 @default.
• W2750448514 hasAuthorship W2750448514A5058439511 @default.
• W2750448514 hasAuthorship W2750448514A5061179981 @default.
• W2750448514 hasAuthorship W2750448514A5065742446 @default.
• W2750448514 hasConcept C121608353 @default.
• W2750448514 hasConcept C126322002 @default.
• W2750448514 hasConcept C143998085 @default.
• W2750448514 hasConcept C2775930923 @default.
• W2750448514 hasConcept C2777329042 @default.
• W2750448514 hasConcept C2777909004 @default.
• W2750448514 hasConcept C2779786085 @default.
• W2750448514 hasConcept C526805850 @default.
• W2750448514 hasConcept C530470458 @default.
• W2750448514 hasConcept C535046627 @default.
• W2750448514 hasConcept C71924100 @default.
• W2750448514 hasConcept C95190672 @default.
• W2750448514 hasConceptScore W2750448514C121608353 @default.
• W2750448514 hasConceptScore W2750448514C126322002 @default.
• W2750448514 hasConceptScore W2750448514C143998085 @default.
• W2750448514 hasConceptScore W2750448514C2775930923 @default.
• W2750448514 hasConceptScore W2750448514C2777329042 @default.
• W2750448514 hasConceptScore W2750448514C2777909004 @default.
• W2750448514 hasConceptScore W2750448514C2779786085 @default.
• W2750448514 hasConceptScore W2750448514C526805850 @default.
• W2750448514 hasConceptScore W2750448514C530470458 @default.
• W2750448514 hasConceptScore W2750448514C535046627 @default.
• W2750448514 hasConceptScore W2750448514C71924100 @default.

• next